Podcasts

New and emerging approaches to lipid lowering

Wednesday, 6 May 2020


In this episode Professor Stephen Nicholls and the expert panel explore where we are now with newer therapies to reduce cardiovascular risk, before taking a peek into the future to see what the next few years will bring.

This is an excerpt from a recent Amgen One Cardiovascular Academy live webcast, hosted by Professor Stephen Nicholls (MonashHeart), in conversation with Professor Steven Nissen (The Cleveland Clinic, Ohio, USA) and Professor Sophia Zoungas (Head of Monash University’s School of Public Health and Preventive Medicine).

the limbic · CV risk reduction: current status and future directions

Amgen One Cardiovascular Academy educational agenda is developed by an independent steering committee comprising Professor Stephen Nicholls, MonashHeart, VIC (Chair), Professor Gemma Figtree, Royal North Shore Hospital, NSW, Professor Anthony Keech, Royal Prince Alfred Hospital, NSW, Professor Karam Kostner, Mater Hospital, QLD, Professor Richard O’Brien, Austin Hospital, VIC, Associate Professor David Sullivan, Royal Prince Alfred Hospital, NSW, Professor Gerald Watts, University of Western Australia, WA and Professor Sophia Zoungas, Monash University, VIC.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic